Getting to the heart of CAR T-cell therapy’s cardiovascular risks
Healio.com,
10 min read Source/Disclosures Disclosures: Frigault reports consultant roles with Celgene, Kite Pharma and Novartis.
10 min read Source/Disclosures Disclosures: Frigault reports consultant roles with Celgene, Kite Pharma and Novartis.
Oncology/Hematology > Hematology MACE in more than 20% of adults treated with novel therapy More than 20% of adult patients who…